PharmiWeb Recruiter Blog

New collaboration leverages MyEyeDr.’s 850+ offices across the US to refer patients into ophthalmology and other therapeutic area clinical trials, expands Parexel’s Community Alliance Network to bring trials to patients where they are

BOSTON and DURHAM, N.C., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced a formal agreement with MyEyeDr., a leading vision healthcare organization, to refer its patients into existing and future ophthalmology clinical trials. Parexel and MyEyeDr. are currently collaborating on recruitment for a diabetic retinopathy clinical trial with future plans to expand into additional therapeutic areas such as endocrinology.

For the first time, Lilly will supply API at a significantly reduced price along with pro-bono technical assistance, enabling EVA Pharma to manufacture and supply insulin to at least one million people in lower income countries

As a Life Science recruiter, you’ll likely have a whole list of repetitive or tedious tasks on your list to complete every week. Whilst these tasks might be necessary to help you achieve your hiring goals, they shouldn’t be taking up more time than they have to – and this is where recruitment automation comes in.

Dublin, Ireland – 13 December 2022 – ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been recognised with a number of coveted business and industry awards over the second half of 2022 for delivering clinical research services, alongside specialist collaborations on data, analytics and digital healthcare.

• Location offers closer proximity to UK capital’s fast-growing global Life Sciences hub, Knowledge Quarter and world-class academic institutions
• Building and location will help GSK achieve ambitious sustainability targets
• Company to open new headquarters in 2024

GSK plc (LSE/NYSE: GSK) today announced that its new global headquarters will be in central London. The company will move to the new headquarters in 2024 from its current location in Brentford, West London.

RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Imago BioSciences, Inc. (Nasdaq: IMGO). On Nov. 21, 2022, Merck announced that it had entered into a definitive agreement to acquire Imago.

Today, Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The combination is expected to unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large.

New Space Will Be Three Times Larger and Increase Testing Capabilities

Video is a powerful tool when it comes to attracting and engaging Life Science talent. In 2022, there was a 57% increase in the number of employers incorporating video into their interview processes compared to pre-pandemic, and this trend is expected to continue in 2023.

The CNS specialist continues its strong expansion course in Europe and increases its presence from two to 20 countries in just six years